Comparative Effects Between ELDOA and Spinal Mobilization With Limb Movement in Lumbar Radiculopathy
Foundation University Islamabad
36 participants
Jun 1, 2025
INTERVENTIONAL
Conditions
Summary
This study examines the comparative effects of ELDOA and Spinal Mobilization with Leg Movement (SMWLM) on lumbar radiculopathy
Eligibility
Inclusion Criteria7
- Age 30 -50 years
- both male and female
- Unilateral lumbar radiculopathy
- Posteriolateral mild disc herniation on MRI
- SLR test positive (30 to 70) degree
- crosed SLR test positive
- Slump test positive
Exclusion Criteria5
- MRI findings indicating i. Spinal instability ii. Significant neuroforaminal stenosis iii. Structural abnormalities requiring surgical intervention (e.g., large disc herniation )
- Clinical findings indicating:
- i. Absence of severe neurological and severe motor weakness (Manual Muscle Testing grades 0, 1, or 2) ii. Signs of cauda equina lesion (e.g., saddle anesthesia, bowel/bladder dysfunction)
- Diagnosed spinal conditions i. Lumbar spondylolisthesis ii. Lumbar spine fracture iii. Spinal stenosis iv. Spinal tumor v. Ankylosing spondylitis
- History of previous spinal surgery Pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will receive a four-week physiotherapy program with three sessions per week. Each session will heat application followed by supervised stretching and strengthening exercises. Participants in Group A will receive ELDOA in addition to standard physiotherapy. Each position will be sustained for at least one minute, with gradual progression to the full posture as flexibility and control improve.
Participants will receive a four-week physiotherapy program with three sessions per week. Each session will heat application followed by supervised stretching and strengthening exercises. Participants in Group B will receive spinal mobilization combined with limb movement along with standard physiotherapy. The technique will be repeated three times.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07328282